IMPAKT 2017 Breast Cancer Conference
Brussels, Belgium - 04 May - 06 May 2017
The IMPAKT 2017 Breast Cancer Conference – organised by the Breast International Group (BIG) and the European Society for Medical Oncology (ESMO), in collaboration with a multidisciplinary alliance of European breast cancer organisations – was held in Brussels, Belgium, 4-6 May 2017.
For news and updates from IMPAKT 2017 on Twitter use the hashtag #IMPAKT17
IMPAKT 2017 News
- High Baseline TIL Levels Signal Superior Responses in HER2-Positive Breast Cancer
- Luminal Androgen Receptor (LAR) Subtype of Triple Negative Breast Cancer (TNBC) Demonstrates In Vitro and In Vivo Sensitivity to CDK4/6 Inhibition
- Few Variations in Somatic Mutations Observed Between Pregnant and Non-Pregnant Patients with Breast Cancer
-
Webcasts
Webcasts and presentations from IMPAKT 2017 can be accessed by ESMO members and conference delegates
-
Programme
The IMPAKT 2017 preliminary programme is now online!
-
Industry Sponsored Satellite Symposia
View the invitations for the satellite symposia that took place during IMPAKT 2017
-
Industry Participation
Industry partners: find out how you can get involved